Get a Deep Insight into The CNS (Central Nervous System) Therapeutics Market

Reportlinker.com announces that a new market research report related to the worldwide neurology industry is now available to its catalogue.

CNS Therapeutics

http://www.reportlinker.com/p053745/CNS-therapeutics.html

This report analyzes the worldwide markets for CNS Therapeutics in Millions of US$.

The specific product segments analyzed are Anti-Alzheimer’s, Anti-Parkinson’s, Anti-Epilepsy, Pain Management (includes Migraine, Nociceptive and neuropathic pain), Anti-Psychotics, Anti-Depressants, and Others (includes Multiple Sclerosis, Insomnia, and ADHD).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual forecasts are provided for each region and product segment for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics.

The report profiles 132 companies including many key and niche players worldwide such as Abbott Laboratories, Akzo Nobel NV, Organon N.V, Alkermes, Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, CeNeS Pharmaceuticals PLC, Cephalon, Inc., Cognetix, Inc., Dainippon Sumitomo Pharma Co., Ltd., Elan Corporation PLC, Eli Lilly and Co, Fabre-Kramer Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Forest Laboratories, Inc., GlaxoSmithKline, H. Lundbeck A/S, Johnson & Johnson, Janssen Pharmaceutica NV, Janssen-Cilag, Merck & Co, Inc., Neurocrine Biosciences, Inc., Novartis AG., Sandoz International GmbH, Ortho-McNeil Neurologics, Inc., Otsuka Pharmaceutical Co., Ltd, Pfizer, Inc., Sanofi-Aventis, Schwarz Pharma AG, Sepracor, Inc., Shire PLC, Solvay Pharmaceuticals, Takeda Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd, UCB S.A., and Wyeth.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of content

I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II.Executive Summary

1. Market Overview

2. Trends and Issues

3. Research & Development

4. CNS Disorders – An Introduction

5. Overview of Select CNS Drugs

6. Product Innovations/Introductions

7. Recent Industry Activity

8. Focus on Select Players

9. Global Market Perspective

III.MARKET

1. The United States

2. Canada

3. Europe

3a. France

3b. Germany

3c. Italy

3d. The United Kingdom

3e. Spain

3f. Rest of Europe

4. Asia-Pacific

5. Latin America

6. Rest of World

IV.COMPETITION

1. Abbott Laboratories (USA)

2. Ablynx (Belgium)

3. Acadia Pharmaceuticals, Inc. (USA)

4. Acumen Pharmaceuticals, Inc. (USA)

5. Akzo Nobel NV (The Netherlands)

6. Alkermes, Inc. (USA)

7. Alpharx, Inc. (Canada)

8. Amarin Corporation PLC (UK)

9. Amorfix Life Sciences Ltd. (Canada)

10. Angiochem, Inc. (Canada)

11. Apotex, Inc. (Canada)

12. Astellas Pharma, Inc. (Japan)

13. AstraZeneca PLC (UK)

14. Avicena Group, Inc. (USA)

15. Avigen, Inc. (USA)

16. Bayer Schering Pharma AG (Germany)

17. Bentley & Remington (P)., Ltd. (India)

18. Biogen Idec, Inc. (USA)

19. Bionomics Ltd. (Australia)

20. Bionovo, Inc. (USA)

21. Biovail Corporation (Canada)

22. Boehringer Ingelheim GmbH (Germany)

23. Boston Life Sciences, Inc. (USA)

24. Brainstorm Cell Therapeutics, Inc. (USA)

25. Bristol-Myers Squibb Company (USA)

26. Britannia Pharmaceuticals Ltd. (UK)

27. CeNeS Pharmaceuticals PLC (UK)

28. Cephalon, Inc. (USA)

29. Ceregene, Inc. (USA)

30. Chakra Biotech Pte., Ltd. (Singapore)

31. China Aoxing Pharmaceutical Corporation (China)

32. Chlorion Pharma, Inc. (Canada)

33. Circadian Technologies Ltd. (Australia)

34. CLL Pharma (France)

35. Cognetix, Inc. (USA)

36. Cortex Pharmaceuticals, Inc. (USA)

37. Cyberkinetics Neurotechnology Systems, Inc. (USA)

38. Dainippon Sumitomo Pharma Company Limited (Japan)

39. Destin Pharma (Germany)

40. DOV Pharmaceutical, Inc. (USA)

41. D-Pharm Ltd. (Israel)

42. Drugfarm Laboratories (India)

43. Eisai Co., Ltd. (Japan)

44. Eisai, Inc. (USA) (A Subsidiary of Eisai Co., Ltd. (Japan))

45. Elan Corporation PLC (Ireland)

46. Elekta AB (Sweden)

47. Eli Lilly And Company (USA)

48. Endo Pharmaceuticals, Inc. (USA)

49. EPIX Pharmaceuticals, Inc. (USA)

50. Ester Neurosciences Ltd. (Israel)

51. Evotec AG (Germany)

52. F. Hoffmann-La Roche Ltd. / Roche Holding Ltd. (Switzerland)

53. Fabre-Kramer Pharmaceuticals, Inc. (USA)

54. Forest Laboratories, Inc. (USA)

55. Galapagos NV (Belgium)

56. Gerolymatos, P. N., SA (Greece)

57. Glaxosmithkline PLC (UK)

58. H. Lundbeck AS (Denmark)

59. Icagen, Inc. (USA)

60. Immune Response Corporation, The (USA)

61. Impax Laboratories, Inc. (USA)

62. Johnson & Johnson (USA)

63. King Pharmaceuticals, Inc. (USA)

64. Kyowa Hakko Kogyo Co., Ltd. (Japan)

65. Lincoln Pharmaceutical Ltd. (India)

66. Lundbeck Espana SA (Spain)

67. MAP Pharmaceuticals, Inc. (USA)

68. Meda AB (Sweden)

69. Medtronic, Inc. (USA)

70. Memory Pharmaceuticals Corporation (USA)

71. Merck & Co., Inc. (USA)

72. Merz Pharmaceuticals GmbH (Germany)

73. Myriad Genetics, Inc. (USA)

74. Neuren Pharmaceuticals Ltd. (New Zealand)

75. Neurim Pharmaceuticals Ltd. (Israel)

76. Neurobiological Technologies, Inc. (USA)

77. Neurochem, Inc. (Canada)

78. Neurocrine Biosciences (USA)

79. Neurogen Corporation (USA)

80. Neurogesx, Inc. (USA)

81. Neurologix, Inc. (USA)

82. Neuromed Pharmaceuticals, Inc. (Canada)

83. NeuroSearch A/S (Denmark)

84. Newron Pharmaceuticals SpA (Italy)

85. Novartis AG (Switzerland)

86. NPS Pharmaceuticals (USA)

87. NsGene A/S (Denmark)

88. Nymox Pharmaceutical Corporation (Canada)

89. Orion Corporation (Finland)

90. Oryx Pharmaceuticals, Inc. (Canada)

91. Otsuka Pharmaceutical Co., Ltd. (Japan)

92. Paris Dakner Microspherules Pvt., Ltd. (India)

93. Pfizer, Inc. (USA)

94. Pharmacopeia, Inc. (USA)

95. PharmaSeed Bioservices (Israel)

96. Pharmidex Pharmaceutical Services Ltd. (UK)

97. Pharmos Corporation (USA)

98. Pozen, Inc. (USA)

99. Prestwick Pharmaceuticals, Inc. (USA)

100. Proneuron Biotechnologies (USA)

101. Proximagen Neuroscience PLC (UK)

102. Purdue Pharma LP (USA)

103. Ranbaxy Laboratories Ltd. (India)

104. Regen Therapeutics PLC (UK)

105. Repligen Corporation (USA)

106. Saila Impex (India)

107. Samaritan Pharmaceuticals, Inc. (USA)

108. Sanofi-Aventis (France)

109. Senexis Ltd. (UK)

110. Sepracor, Inc. (USA)

111. Shire Pharmaceuticals Group PLC / Shire PLC (UK)

112. Solvay Pharmaceuticals (France)

113. Somerset Pharmaceuticals, Inc. (USA)

114. Spectrum Pharmaceuticals, Inc. (USA)

115. StemCells, Inc. (USA)

116. Sygnis Pharma AG (Germany) -264

117. Takeda Pharmaceutical Company Limited (Japan)

118. Targacept, Inc. (USA)

119. Teva Pharmaceutical Industries Ltd. (Israel)

120. Titan Pharmaceuticals, Inc. (USA)

121. Torreypines Therapeutics, Inc. (USA)

122. Toyama Chemical Co., Ltd. (Japan)

123. Transition Therapeutics, Inc. (Canada)

124. UCB SA (Belgium)

125. Vernalis PLC (UK)

126. VistaGen Therapeutics, Inc. (USA)

127. Voyager Pharmaceutical Corporation (USA)

128. Wyeth (USA)

129. Xenoport, Inc. (USA)

130. Zentiva, AS Praha (Czech Republic)

131. Zogenix, Inc. (USA)

132. Zydus Cadila Healthcare Ltd. (India)

More market research reports? Go to http://www.reportlinker.com

http://www.reportlinker.com/Rss/en02092/cns-free-market-research- reports.xml

http://www.reportlinker.com/Rss/en015956/neurological-disorder- free-market-research-reports.xml

http://www.reportlinker.com/Rss/en012910/neurological-disorders- free-market-research-reports.xml

http://www.reportlinker.com/Rss/en015970/neurology-free-market- research-reports.xml

http://www.reportlinker.com/Rss/en012737/neuropathic-pain-free- market-research-reports.xml

http://www.reportlinker.com/Rss/en06649/neuroprotection-free- market-research-reports.xml

(Due to their length, these URLs may need to be copied/pasted into your Internet browser’s address field. Remove the extra space if one exists.)